Terri Lynn Shigle (Roy F Chemaly)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Stem Cell Transplantation

Drug Administration

Top Venues

Bone marrow transplantation

Therapeutic advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Alejandro Marinos, Jeremy L Ramdial, Fareed Khawaja, Rima M Saliba, Terri Lynn Shigle, Amin M Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, Richard E Champlin, May Daher, George Chen, David Marin, Katayoun Rezvani, Elizabeth J Shpall, Roy F Chemaly
Hematopoietic cell transplantation can be safely performed after COVID-19. Bone marrow transplantation (2023)
Uday R Popat, Oren Pasvolsky, Roland L Bassett, Rohtesh S Mehta, Amanda L Olson, Julianne Chen, Amin Majid Alousi, Gheath Al-Atrash, Qaiser Bashir, Alison M Gulbis, Chitra M Hosing, Jim S Im, Partow Kebriaei, Issa F Khouri, David C Marin, Yago L Nieto, Betul Oran, Neeraj Y Saini, Terri Lynn Shigle, Samer A Srour, Jeremy Leon Ramdial, Katayoun Rezvani, Muzaffar H Qazilbash, Borje S Andersson, Richard E Champlin, Elizabeth J Shpall
Myeloablative Fractionated Busulfan for Allogeneic Stem Cell Transplant in Older Patients or Patients with Comorbidities. Blood advances (2023)
Terri Lynn Shigle, Victoria Wehr Handy, Terri Lynn Shigle
Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant. Therapeutic advances in hematology 11 (2020)